Grayline Clinical Drug Trials
Wichita Falls, Texas, United States
Research foundation in Wichita Falls, Texas
3300 Seymour Hwy, Wichita Falls, TX 76309
About Grayline Clinical Drug Trials
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
8
Naurex, Inc, an affiliate of Allergan plc
4
Shire
4
Sunovion
4
Biohaven Pharmaceuticals, Inc.
3
Boehringer Ingelheim
3
ACADIA Pharmaceuticals Inc.
2
Athira Pharma
2
Bristol-Myers Squibb
2
Corcept Therapeutics
2
Janssen Research & Development, LLC
2
Clinical Trials at Grayline Clinical Drug Trials
During the past decade, Grayline Clinical Drug Trials conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 24 clinical trials were completed, i.e. on
average, 96% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 11 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)
2004-04-01
2007-09-01
Completed
280
Mifepristone as Adjunctive Therapy in Alzheimer's Disease
2003-04-01
2005-11-01
Terminated
160
A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression
2004-09-01
2006-06-01
Completed
257
An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type
2003-02-01
Completed
430
ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)
2005-09-01
Completed
555
Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
2007-06-01
2008-12-01
Completed
257
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
2008-01-01
2008-12-01
Completed
456
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Grayline Clinical Drug Trials" #1 sponsor was "Pfizer" with 8 trials, followed by "Naurex, Inc, an affiliate of Allergan plc" with 4 trials
sponsored, "Shire" with 4 trials sponsored, "Sunovion" with 4 trials sponsored and "Biohaven Pharmaceuticals, Inc."
with 4 trials sponsored. Other sponsors include 26 different institutions and
companies that sponsored additional 29 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Grayline Clinical Drug Trials"
#1 collaborator was "APCER Life Sciences" with 1 trials as a collaborator, "INC Research Limited" with 1 trials as a collaborator, "Institute for the Study of Aging (ISOA)" with 1 trials as a collaborator, "KCAS Bio" with 1 trials as a collaborator and "Neumora Therapeutics, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Grayline Clinical Drug Trials
According to Clinical.Site data, the most researched conditions in "Grayline Clinical Drug Trials" are
"Major Depressive Disorder" (10 trials), "Alzheimer's Disease" (9 trials), "Alzheimer Disease" (5 trials), "Depressive Disorder, Major" (5 trials) and "Osteoarthritis" (4 trials). Many other conditions were trialed in "Grayline Clinical Drug Trials" in a lesser frequency.
Clinical Trials Intervention Types at Grayline Clinical Drug Trials
Most popular intervention types in "Grayline Clinical Drug Trials" are "Drug" (52 trials), "Other" (6 trials) and "Biological" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (25 trials), "placebo" (6 trials), "Rapastinel" (4 trials), "ATH-1017" (2 trials) and "BI 1358894" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Grayline Clinical Drug Trials
The vast majority of trials in "Grayline Clinical Drug Trials" are
54 trials for "All" genders.
Clinical Trials Status at Grayline Clinical Drug Trials
Currently, there are NaN active trials in "Grayline Clinical Drug Trials".
undefined are not yet recruiting,
7 are recruiting,
undefined are Active, not recruiting,
and 2 are Enrolling by invitation.
In total, there were 32 completed trials in Grayline Clinical Drug Trials,
undefined suspended trials,
and 12 terminated clinical trials to date.
Out of the total trials that were conducted in Grayline Clinical Drug Trials, 0 "Phase 1"
clinical trials were conducted, 21 "Phase 2" clinical
trials and 32 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 0 trials that are defined as “Not Applicable".